Tag: CRO governance

Using Metrics and KPIs to Demonstrate Ongoing Sponsor and CRO Oversight In today’s landscape of clinical research, effective monitoring and oversight by sponsors and Contract Research Organizations (CROs) are imperative for successful clinical trial management. The utilization of metrics and Key Performance Indicators (KPIs) has become a standard practice that allows clinical operations professionals, regulatory…

Read More “Using Metrics and KPIs to Demonstrate Ongoing Sponsor and CRO Oversight” »

Managing GCP Risk When Working With Site Networks and SMOs In today’s clinical research landscape, Good Clinical Practice (GCP) compliance is essential, particularly when working with Site Management Organizations (SMOs) and site networks. As a clinical operations, regulatory affairs, or medical affairs professional, understanding the complexities of these relationships is crucial to ensuring the quality…

Read More “Managing GCP Risk When Working With Site Networks and SMOs” »

Escalation Paths and Decision Rights for GCP-Critical Issues Escalation Paths and Decision Rights for GCP-Critical Issues 1. Introduction to GCP Compliance and Its Importance Good Clinical Practice (GCP) guidelines are essential in compliance with international ethical and scientific quality standards in clinical research. GCP ensures the protection of human subjects and the credibility of clinical…

Read More “Escalation Paths and Decision Rights for GCP-Critical Issues” »

Global Program Governance: Study SteerCos, QMS and Quality Councils Global Program Governance: Study SteerCos, QMS and Quality Councils In the rapidly evolving landscape of clinical research, effective governance structure is essential for successful outcomes. Organizations engaged in the conduct of clinical trials must navigate complex regulatory environments across multiple jurisdictions while maintaining high standards of…

Read More “Global Program Governance: Study SteerCos, QMS and Quality Councils” »

Inspection Readiness for Sponsors and CROs Across Portfolios Inspection Readiness for Sponsors and CROs Across Portfolios Introduction to Inspection Readiness In the realm of clinical research, particularly in edge clinical trials, maintaining an optimal level of inspection readiness is paramount for sponsors and Contract Research Organizations (CROs). Inspection readiness entails ensuring that all processes, documentation,…

Read More “Inspection Readiness for Sponsors and CROs Across Portfolios” »

Auditing CROs and Vendors: Evidence Regulators Expect to See Auditing CROs and Vendors: Evidence Regulators Expect to See In the complex landscape of clinical research, effective oversight of Contract Research Organizations (CROs) and vendors is essential for ensuring compliance with Good Clinical Practice (GCP) regulations. This tutorial guide provides a comprehensive framework for auditing CROs…

Read More “Auditing CROs and Vendors: Evidence Regulators Expect to See” »

Contractual Language That Clearly Allocates GCP Responsibilities Contractual Language That Clearly Allocates GCP Responsibilities In the complex realm of clinical trials, particularly in the context of Good Clinical Practice (GCP), the clarity of contractual language is paramount. This article serves as a step-by-step tutorial for clinical operations, regulatory affairs, and medical affairs professionals in the…

Read More “Contractual Language That Clearly Allocates GCP Responsibilities” »

Oversight of Monitoring, Data Management and Statistical Functions Under GCP Oversight of Monitoring, Data Management and Statistical Functions Under GCP Good Clinical Practice (GCP) guidelines set forth by regulatory authorities such as the FDA, EMA, and MHRA outline the necessary requirements for the conduct of clinical trials. This tutorial serves as a comprehensive guide focused…

Read More “Oversight of Monitoring, Data Management and Statistical Functions Under GCP” »

Sponsor Responsibilities in Decentralized and Platform Trial Models Sponsor Responsibilities in Decentralized and Platform Trial Models Introduction to Decentralized and Platform Trials In the evolving landscape of clinical research, decentralized and platform trial models have gained prominence, offering opportunities to enhance patient engagement, improve efficiency, and broaden the scope of data collection. These novel methodologies…

Read More “Sponsor Responsibilities in Decentralized and Platform Trial Models” »

Risk-Based Quality Management Systems for Sponsors and CROs In the realm of clinical trials, particularly in contexts such as non-small cell lung cancer clinical trials, the implementation of a Risk-Based Quality Management System (RBQM) is essential for ensuring compliance and enhancing the quality of research. This guide provides a comprehensive overview of RBQM systems for…

Read More “Risk-Based Quality Management Systems for Sponsors and CROs” »